Nephrology Associates

Menu:

Research Opportunities/Clinical Trials

Nephrology Associates actively participates in research studies and ongoing clinical trials that are appropriate for patients with chronic kidney disease.

If you have any concerns about a clinical trial or are interested in being an active participant in trials and want to know what trials the office is actively participating in, please feel free to contact the office and ask to speak to Theresa Moore, RN, NP, Research Coordinator.


Past Clinical Trials ~ Anemia Matters

  • AMPS I ~ Sept 2003 - April 2004
  • AMPS II ~ Sept 2003 - April 2004
  • Strata Study ~ Sept 2004 - June 2005
  • AMG00178 Protocol ~ Sept 2005 - Feb 2006
  • Anemia Matter Study ~ June 2006
  • Speedel Study ~ Dec 2006
  • Roche PD Anemia ML20338 ~ April 2007 - Dec 2007


  • Current Clinical Trials

  • Affymax 001 Anemia Study ~ Dec 2007 - Present




  • Anemia Clinic

    Anemia is a common problem in patients with chronic kidney disease. Most patients who develop chronic kidney disease will become anemic at some point and will require a medication called Aranesp. Aranesp is a subcutaneous injection given every 2 weeks or monthly in our office to help your body produce red blood cells. Your physician or nurse practitioner will tell you at what point you will need to start Aranesp therapy. The clinic operates 5 days a week, Monday through Friday from 8:30am - 5pm. Patients are followed closely by the nurses in the clinic and doses are given appropriately based on patients' hemoglobin levels. You will most likely also be asked to take iron if you are on Aranesp.

    If you have any question about anemia or feel that maybe you should be on this medication, please talk to your physician or nurse practitioner regarding this.